This SMI CalAdviser consultation service is not intended to serve as a guideline or directive for individual patient care management. It should not be considered a statement of the standard of care or inclusive of all potential treatments or methods of care. Information about any diagnoses, procedures, medications, or other courses of treatment discussed in this consultation is provided for educational purposes only. Ultimate treatment decisions must be made by the treating clinician, in light of each individual patient’s specific conditions and possible contraindications or dangers in use, applicable manufacturer product information, the psychiatric and medical evidence, other relevant clinical data, and diagnostic and treatment options available for such patient. This consultation may include discussion of unlabeled and/or investigational uses of agents that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses. APA does not endorse or recommend use of any pharmaceutical or other device. The decision to use any particular pharmaceutical is solely up to the prescriber. Effort has been made in preparing this consultation to provide accurate and up-to-date information that is in accord with accepted standards and practice at the time of release. Nevertheless, APA and its consultants provide the consultation on an “as is” basis and make no warranties, expressed or implied, regarding the consultation, including that the information contained herein is free from error. APA and its consultants assume no responsibility and fully disclaim all liability for any injury or damage to persons or property arising out of or related to any use of this consultation or for any errors or omissions. Users of the consultation service may not include protected health information (PHI) in the request submitted through this portal or any subsequent discussion; if a user identifies that inclusion of PHI (or a chart review) is necessary for a consultation request, they  should input only their contact information and their request will be routed to the California Department of State Hospital’s Psychopharmacology Resource Network (PRN) to address .

By initiating this consultation, you warrant that you: (i) are currently a practicing provider of the type selected above who is authorized to use the SMI CalAdviser consultation service; (ii) will not impersonate any other person or entity or defame or otherwise harm any party, including APA, through your use of this consultation; and (iii) will not include any protected health information (PHI) or other personal data belonging to any third party in your submission or subsequent discussion related to this consultation. To the fullest extent permitted by law, you shall indemnify and hold harmless APA and its consultants from and against any and all claims, damages, or liabilities arising from or related to your use of the consultation, the information provided by APA herein, or your failure to comply with these terms.

The SMI CalAdviser consultation service may not be used for immediate, or urgent medical or mental health needs. For life-threatening emergencies call 911; the 988 Lifeline may be called to receive support for a mental health-related crisis.

By initiating this consultation, you represent that you are a mental health clinician authorized to use the SMI CalAdviser consultation service and agree that you have reviewed and accept these terms.